Development of cryptogenic fibrosing alveolitis during pregnancy

Densem, Cameron; Niven, Robert; Barber, Philip; Bishop, Pau
November 1998
Journal of the Royal Society of Medicine;Nov1998, Vol. 91 Issue 11, p591
Academic Journal
The article reports on the case of a 29-year-old woman who developed cryptogenic fibrosing alveolitis (CFA) during pregnancy. There was no sputum production or chest pain. She was an ex-smoker of 20 cigarettes per day for 15 years but have given up at the start of the pregnancy. She was treated with oral prednisolone which proved to be successful and she later gave birth to a healthy baby.


Related Articles

  • Lung Remodeling in Interstitial Pneumonia: A New Molecular Target of Pulmonary Fibrosis. Sunohara, Mitsuhiro; Takizawa, Hajime // Current Respiratory Medicine Reviews;2005, Vol. 1 Issue 1, p93 

    It is well demonstrated that inflammatory processes in the interstitium are pivotal as the pathological features of idiopathic interstitial pneumonia (IIP). Standard therapy with corticosteroids may suppress such inflammatory changes, but not result in marked clinical benefits, especially among...

  • Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases? Dhooria, Sahajal; Agarwal, Ritesh; Gupta, Dheeraj // Lung India;Jan/Feb2015, Vol. 32 Issue 1, p4 

    The author reflects on an article regarding the successful treatment of connective tissue disease (CTD)-associated interstitial lung disease (ILD) with pirfenidone, an active drug with anti-inflammatory and anti-fibrotic actions, in a patient with systemic sclerosis (SSc). He outlines the...

  • Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model. Milara, Javier; Morcillo, Esteban; Monleon, Daniel; Tenor, Herman; Cortijo, Julio // PLoS ONE;7/20/2015, Vol. 10 Issue 7, p1 

    Fibrotic remodeling is a process common to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, acute respiratory distress syndrome and asthma. Based on preclinical studies phosphodiesterase 4 (PDE4) inhibitors may exhibit beneficial anti-inflammatory...

  • Smoking-Related ''Interstitial'' Lung Disease. Franks, Teri J.; Galvin, Jeffrey R. // Archives of Pathology & Laboratory Medicine;Aug2015, Vol. 139 Issue 8, p974 

    Context.--Emphysema, respiratory bronchiolitis, des-quamative interstitial pneumonia, pulmonary Langerhans' cell histiocytosis, small-airway injury including submuco-sal and adventitial fibrosis, increased bronchus-associated lymphoid tissue, and small artery/arteriolar wall thickening are...

  • NEWS ROUNDUP. Dziedzic, Jessica // Pulmonary Reviews;Sep2007, Vol. 12 Issue 9, p3 

    This section offers news briefs related to pulmonary medicine. A study in New Zealand found that a change in the criteria used to diagnose airflow obstruction resulted in a marked decrease in COPD prevalence in a cohort of 749 study participants. According to a study of the National Center for...

  • Resveratrol Investigated as Treatment for Lung Disease. Mitchell, Terri // Life Extension;Mar2004, Vol. 10 Issue 3, p17 

    Reports that researchers at the National Heart and Lung Institute in London, England, are examining the phyto-vitamin resveratrol as a possible treatment for chronic obstructive pulmonary disease. Cause of the disease usually by cigarette smoking; Indication that resveratrol may work better...

  • Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products. Naik, Pooja; Cucullo, Luca // Fluids & Barriers of the CNS;10/31/2015, Vol. 12, p1 

    Tobacco smoke (TS) is the leading cause of preventable deaths worldwide. In addition to a host of well characterized diseases including chronic obstructive pulmonary disease, oral and peripheral cancers and cardiovascular complications, epidemiological evidence suggests that chronic smokers are...

  • Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages. Mortaz, Esmaeil; Adcock, Ian M.; Ricciardolo, Fabio L. M.; Varahram, Mohammad; Jamaati, Hamidreza; Velayati, Ali Akbar; Folkerts, Gert; Garssen, Johan // PLoS ONE;8/28/2015, Vol. 10 Issue 8, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is a major global health problem with cigarette smoke (CS) as the main risk factor for its development. Airway inflammation in COPD involves the increased expression of inflammatory mediators such as CXCL-8 and IL-1β which are...

  • The anti-inflammatory and anti-remodeling effect of tiotropium bromide in the subacute cigarette exposure mouse model. Eraldemir, Fatma Ceyla; Şengül, Aysun; Özkan, Meyrem; Köktürk, Sibel; Özsoy, Doğa; Yıldız, Firuzan Akar // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 11, p22824 

    Chronic obstructive pulmonary disease is an inflammatory lung disease mainly caused by cigarette smoke inhalation. We aimed to evaluate the effect of tiotropium bromide, which is an anticholinergic bronchodilator, on inflammation and remodeling in the subacute cigarette exposure mice model....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics